Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples.
DYRK1A
FoxM1
LIN9
MYBL2
cancer genome atlas
protein complex
transcription
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
12
2020
accepted:
08
02
2021
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
23
3
2021
Statut:
epublish
Résumé
Cell cycle control drives cancer progression and treatment response in high grade serous ovarian carcinoma (HGSOC).
Identifiants
pubmed: 33747961
doi: 10.3389/fonc.2021.637193
pmc: PMC7969987
doi:
Types de publication
Journal Article
Langues
eng
Pagination
637193Subventions
Organisme : NCI NIH HHS
ID : F30 CA221004
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188571
Pays : United States
Informations de copyright
Copyright © 2021 Iness, Rubinsak, Meas, Chaoul, Sayeed, Pillappa, Temkin, Dozmorov and Litovchick.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancer Res. 2008 Jul 1;68(13):5478-86
pubmed: 18593951
Oncogene. 2019 Feb;38(7):1080-1092
pubmed: 30206359
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Nucleic Acids Res. 2019 Dec 2;47(21):11197-11208
pubmed: 31667499
Mol Cancer Res. 2017 Apr;15(4):371-381
pubmed: 28031411
Am J Surg Pathol. 2010 Mar;34(3):433-43
pubmed: 20154587
Cell Death Dis. 2017 Jun 22;8(6):e2895
pubmed: 28640249
Am J Pathol. 2016 May;186(5):1103-13
pubmed: 26993207
Gynecol Oncol. 2019 May;153(2):312-319
pubmed: 30853361
Oncogene. 2017 Jan 5;36(1):110-121
pubmed: 27212033
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
pubmed: 20610543
Clin Cancer Res. 2005 May 15;11(10):3686-96
pubmed: 15897565
J Clin Oncol. 2005 Oct 1;23(28):6890-8
pubmed: 16129845
Cell Rep. 2018 May 29;23(9):2758-2769
pubmed: 29847804
Genes Dev. 2011 Apr 15;25(8):801-13
pubmed: 21498570
Mol Cell Biol. 2013 Jan;33(2):227-36
pubmed: 23109430
Mol Cancer Res. 2018 Jun;16(6):961-973
pubmed: 29545475
Nat Rev Cancer. 2013 Aug;13(8):585-95
pubmed: 23842645
Cancer Cell. 2009 Dec 8;16(6):521-32
pubmed: 19962670
J Natl Cancer Inst. 2013 May 15;105(10):701-10
pubmed: 23641039
Int J Cancer. 2018 Dec 1;143(11):2973-2984
pubmed: 30129654
Oncotarget. 2015 Sep 29;6(29):27613-27
pubmed: 26243836
J Natl Cancer Inst. 2010 Feb 3;102(3):161-9
pubmed: 20071686
PLoS One. 2012;7(2):e31761
pubmed: 22393369
Nat Cell Biol. 2014 Jun;16(6):538-49
pubmed: 24776885
Expert Opin Ther Targets. 2019 Mar;23(3):161-164
pubmed: 30724632
Cancer Res. 2009 May 1;69(9):4073-80
pubmed: 19383908
Genes Dev. 2012 Mar 1;26(5):474-89
pubmed: 22391450
Oncotarget. 2017 Feb 14;8(7):11160-11172
pubmed: 28061449
Nat Genet. 2006 Sep;38(9):1043-8
pubmed: 16921376
Cancer Res. 2017 Oct 1;77(19):5395-5408
pubmed: 28807940
Nucleic Acids Res. 2016 Jul 27;44(13):6070-86
pubmed: 27280975
Anal Biochem. 2009 Nov 1;394(1):110-6
pubmed: 19622337
Front Oncol. 2018 Jun 11;8:223
pubmed: 29942794
Int J Gynecol Cancer. 2017 Oct;27(8):1602-1609
pubmed: 28692634
Database (Oxford). 2013 Apr 02;2013:bat013
pubmed: 23550061
Biochim Biophys Acta. 2014 Nov;1839(11):1316-22
pubmed: 25287128
Neoplasia. 2004 Jan-Feb;6(1):1-6
pubmed: 15068665
Mol Cell. 2007 May 25;26(4):539-51
pubmed: 17531812
J Pathol. 2014 Apr;232(5):522-33
pubmed: 24374933
Breast Cancer Res Treat. 2013 Jul;140(2):219-32
pubmed: 23836010
Clin Cancer Res. 2008 Aug 15;14(16):5198-208
pubmed: 18698038